A protective role for nitric oxide in the oxidative modification of low density lipoproteins by mouse macrophages  by Yates, Mark T. et al.
'Volume 309, natal:mr 2, 135-1;18 FEB$11487 
© 1992 Federation of European Biochemical Societies O0145"/9~U92P$5,00 
~¢ptemtmr 1992 
A protective role for nitric oxide in the oxidative modification of low 
density lipoproteins by mouse macrophagcs 
Mark T. Yules, Laurie E. Lambert, Jeffrey P. Whitt¢n, Inn McDonald, Masayuki Mann, George Ku and 
Simon J.T. Moo 
Marion Mcrrell Dow Research Instinee, 2110 E. Gatbraith Road. Ctnehmati. OH 45213, USA 
geexiv¢d 22 lune 1992: revised version r~ived 20 July 1992 
Low denfity lipoprot¢ins (LDL) oxidati~ly modified by maeropha~s have been shown to tm atherogeni¢ n~ vivo studio, W= studied the potential 
role of nitric oxide (NO), a free r-adi~l produt:ed by maerophag=;, in LDL modifi~tion, Human LDL (I mg/ml) were incubated with mouse 
Ixritom:al ma¢rophag~ in Ham's F-IO medium. The ¢¢1ls w=r¢ then stimulat~ by interferon.y and tumor n¢¢rosi= fa=or-¢ to inerea~ their 
production of NO from t.3 to 12.2 tam in 24 h. us mcatsured by nitrite. Lipid l~roxidation f LDL, as m~sured by thio~rbitudc a id.tractive 
materials (";'BARS). was reduexd instimulated c¢{l~ in a time.dependent manner. At 24 h, the d=rcar¢ ~s  about 2"/%. In tl;¢ preu:n¢¢ ofan NO 
syntha~ inhibitor (N".aminophomoarginin¢). the Ilcncration of NO was diminished and tim proration a~init LDL lipid pcroaidation wa~ 
reverted, The extent of LDL protein modifiemtion was al~ assessed by examining its electropho~tic mobility. It wall found that macrophage NO 
reduced the change in LDL ¢lectromobility, These data ladS=ate that the production of NO may inlfibit the oxidative modification of LDL with 
cytokine,stimulatcd macrophag¢*, We suggest hat NO plays a protective role in limiting macrophage.indutu=d LDL modifl=ation, 
Low density lirmprotein: Oxidation: Nitric oxide: Macrophage: Atlmros¢lerosis 
t. INTRODUCTION 
The accumulation of lipid-laden foam cells derived 
from macrophases in the aortic intima is an early event 
in atherogenesis [1.-'/], Studies haw suggested that lipid 
peroxidation of low density lipoproteins (LDL)  indued 
by  free radicals can increase th= atherogenicity of LDL 
[8-14], The~= oxidized LDL arc r¢cogniz.cd and taken 
up by macrophage scavenger receptors leading to foam 
cell formation [15,16], In the presence of an antioxidant, 
such as probucol, the formation of foam ~lls is inhib- 
ited both in vitro and in vivo [17-21]. However, the 
sources and species of those free radicals responsible for 
the oxidation of LDL are not well established, The su- 
peroxid¢ anion (Of) produced by macrophages i
known to be involve, s in~ the pretreatment of macro- 
phages with superoxid¢ dismuta~e (SOD) attenuates 
LDL lipid peroxidation [22]. Macrophages have been 
shown to produce the nitric oxide (NO) radical via nitric 
oxide synthase. This enzyme converts arginine into cit- 
rulline and is indued by cytokin, treatment [23,24], 
Although NO can neutrali~ Oi- to form a stable per- 
oxynitrit¢ anion (ONOO') [25], under some conditions 
th¢ peroxynitrit¢ can also rapidly decompose to form a 
strong oxidant with reactivity similar to the hydroxyl 
radical [26]: 
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O~" + NO'~ ONOO" 
ONOO" + H* m ONOOH ~ HO' + NO'_, 
In addition. NO generation in vivo may lead to the 
mobilization of iron with a subsequent increase in the 
level of  reactive oxygen slzt¢ics [2?]. These observation= 
could ¢~plain the cytotoxi¢ action of NO that has been 
demonstrated in a numL~r of studies [28,29]. The pur- 
pose of  the present study was to dctermin, the , f f~t  of 
NO production by macrophagcs on LDL lipid [mroxi. 
datioa. To this end we incubated LDL with macro- 
phages in which the synthesis of  NO was induced with 
interf¢ron-7 and tumor necrosis factor-~, and followed 
the extent of oxidative modification of  LDL. 
2. MATERIALS AND METHODS 
2,i, Nitric oxide .¢k.tztha~'e inhibitor (MDL lO0.24tt) 
$-Mcthylisothio~emi~ar "b tde hydroio,Jid¢ (17,8 . 0.0?fi tool) was 
added to L-ly£n¢ monohydrate (9,3 $, 0,076 tool) in water (t00 ml) and 
adjusted to pH 9.5 with I N NaOH, The r~gtion mi~tu~ wa= h~t~ 
and stirred at 40"C for 30 h. The solution was then cooled to room 
teml~rature and acidified to pH 4.0 with acetic acid. F~vianic acid 
(20 g) was dzcn add~.xl to the mixture and cooled to O'C. The resultin~ 
pr~ipitat¢ was then filtered and rc=wstatlized from water to yield 
13.2 II t-'N°-aminohomoarg inin~ flavinat¢. The 5olid was then plac, d 
on a bed of 200..400 mesh AG2.XtI chloride from ion.exchange r~in 
in u soxhlct extraction thimble and eluted with hot water. The solution 
wB~ ly,phi!'_=~ -and the re~ultin 8 hydroscopi, solid taken up in meth- 
anol (75 ml) aud pr,~ipitatcd asthe fr~ base by the addition o1" 
propylene oxide (10 ml), 
The arginine analogue, MDL 100,248, was freshly prgpared as a 
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s~ctsk roluGon (100 mM) in dimcthylsulfoxidc (ME.$O). The soktian 
was then diluted IO the upproprirtc cunccntnlion in mcdiunr und filter 
rkrilizcd prior IO use in the runy. 
tow dcnriiy lipoproteins (LDL) were isal~rted from human plasma 
usins scqucntinl ullracenlrifugnlion al I~ density of 1.019-1.063 @III 
[JO]. The frnhly prepared tDL wcrc c~lcnrivcly di;dyncd aguinrlO.012 
M phospharc-buffcrcd saline (PBS)contuiningpcnicillin G (IBa Uhl) 
und rtrcptomycin (LOO U/ml) tmd stored ut 4% The protein CQR~CR- 
trationofLDLwnrdctcrmincd by thcmcthodof Lowryctal. [fl] with 
minor modilknlion [30), 
Raidcnt peritoneal macropha#s wcrc hnrvcrtcd from 24 mnlc 
CD-I mice (I 620 g) (Charles Riwcr) and washed Ix with Dulbocco’s 
modified Eqlc’r medium (DMEM) und Ix with DMEM containing 
IO% feral bovine serum (C&co). The eclls wcrc added to 24.well tirruc 
cul~urc plater PI 2 x IQ collJwcll in DMEM containing IO% fclol 
bovine serum, and cuhursd for % h at 37% in an incubator tdnhinin# 
5lbCO: with 90% humidity. The non-udhcrcnt ells wcrc rcmovcd and 
thc monolaycrswcrc then placcd in rrum~frcc DMEM or Mum’s F-IO 
mtdium (Giko). In the aimulatcd macrophugc uhurcs. rccombinunl 
intcrfcron-7 (IFN-7. Amgcn) and tumor necrosis factor-u (TNFe, 
Gcnzymc) wcrc each added a~ 1 .wW U/ml. In those cultures in which 
NO production was inhibited, cytokinc trcatmcnt was prcccdcd by II= 
uddition of the araininc nnnloguc, L.PIQ.nminohomoarnininc (200 
PM). Control monokycrs wcrc cultured without stimulating ugcnts. 
t-lumen LDL (IOfJro) wcrc immcdiatcly sddcd 10 each cukurc is the 
uppropriatc medium with n final volume of I mlkcll. 
At each period of 0. 5, I4 and 24 h IL cultures wcrc Iwvcscd in 
triplicuk to assess the oxidstivc modifu&on of LDL. Total lipid 
psronidnlion in the ccl1 rupcrnrrtnnt (urztlying 50 fig af LDL) was 
dckrmincd Und crprcsscd as thiobarbituric orid-rcuctivc substances 
(TBARS) using matondiuldchydo (MDA) as P standard [ 191. Aprrosc 
gel cltctrophorcris was pcrfonnd ta cvutunu the clcctropharc~ic ma* 
bility of the LDL. Aliquots of the culture supsrnat~nu (250~1) wcrc 
conccnrrutcd five-fold usin& u ccnlric4n-30 microconccmrator appa- 
ratus (Amicon). This wns performed by ccntrifugation at 4,000 rpm 
(2.5W x g) for I5 min a~ 4.C. 3 PI of the conccntratcd slunplcs were 
irpplicd IO a I% agarosc gel snd clcctrophorcsir was pcrfornrcd with 
LL 9OB power supply for 35 min (Gibe-Corning)_ 711~ gel was dried for 
I h at 6O’C und stained with FUI red 76 (Siym;l). 
2.5. M(rrropilugc El0 prolhtcrlor, 
Mtlcrophagc NO synthesis was mcururcd indirectly OI the nitrite 
conccmrution in the culture medium. 100~1 of the rrqcrnatant fluid 
wcrc urcd to dcrcrminc the lcvcl of nitrite in the manner described by 
Sruchr und Nuhm [?9], 
3. RESULTS AND DISCUSSION 
The purpose of this study was to cxplorc the possible 
role of NO radicals produced From macrophaacs in 
LDL lipid peroxidation, Sines LDL can bs directly ox- 
idized and modified by pcroxyl radicals (MOO’) gcncr- 
atcd via the thermolysis of azo compounds [32], WC 
tested whether or not the production of NO radicals by 
macrophagcs may also oxidativcly modify LDL. First, 
WC used cytokinss to stimulate NO synthasc in macro- 
phages resulting in the overproduction of NO. Fig. I 
shows that there was a Z-fold increase in NO produc- 
tion in stimulated cells cultured in DMEM medium for 
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ecus COllS*inhibilOl 
Fig. I. Effcu of NO production (A) on thr lipid pronidation (B) of 
LDL incubated with mlrcrophagcs for 24 h in DMEM culture inc. 
dium. NO productian wnr stimulated by IFN-7 nnd TNF-a with and 
withoul an NO rynthasc inhibitor and mcururcd indirectly :II nitrite. 
NO was no: dctcctablc in medium conlaining LDL nlonc. TBARS 
wcrc cxprcrscd usinp malondilrldchydc (MDA) 11s a rcfcrcncc and wcrc 
inrignilicant in cuhurcd medium without LDL. Each bnr rcprncntr 
the mean I S.E.M. of three cxpcrimcntr. ‘P < 6.005 11s compared to 
LDL *cells. :P c 0.001 urcompnrcd IO LDL + medium. *P = 0.03 as 
camparcd to LDL + rtimulatcd cells. 
lipid pet-oxidation of LDL. as measured by TBARS, A 
slight, but not statistically significant. dccrcasc was ob= 
served (Fig, IB). 
In theory, if NO protects against macrophagc-mcdi- 
atcd LDL oxidation, stimulated cells treated with n spc- 
cific NO synthnsc inhibitor would demonstrate cn- 
hanccd oxidation. WC show that with the synthase in- 
hibitor (L-NC-aminohomoargininc) the production of 
NO was reduced below dctcctablc lrvcls (Fig. IA), and 
that LDL oxidation was increased (P =0.03) compared 
to stimulated cells without the inhibitor (Fig. 1B). WC 
also tcstcd the possibility that the increase of lipid per- 
oxidation of LDL was due to the interference of the 
inhibitor with TBA in the assay. It was found that the 
inhibitor (200pM) neither changed the formation of the 
MDA-TBA complex nor astcd as a pro-oxidant to 
LDL lipid pcroxidation mcdiatcd by CL?’ (data not 
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Fig. 1. Effect of NO production (A) on the lipid pcroxidution (6) of 
LDL incubntcd with macrophugcs in F-IO cuhurc medium. Expcri- 
mental conditions were idcntkl to thou dc5crribcd in Fig. I. TDARS 
wcrc inrignificunt in cultured medium without LDL. Cells wcrc stim- 
ulated by IFN-), ond TNF-a ilt 0 h. hsh b&r rcprcrents the mciln 2 
S.E.M. of three cxpcrimmtr; ‘P < 0.005 LLS compared to LDL + ccllr. 
:P e 0.005 us compared to LDL + rtimulirtcd ccllr. 
shown), The data suggest chat NO radicals do not con- 
tribute co accclcrotcd lipid psroxidation in our system. 
In the next cxpcrimcnt, cells were cultured in Ham’s 
F-10 medium. which has previously been shown to cn- 
hnncc macrophagc-mediated LDL oxidation [ 121. WC 
show that TBARS were dramaticaliy incrcascd by the 
macrophngcs cultured in this medium in a time-depend= 
cnc manner (Fig. 21, however, TBARS were sign& 
crrntly less (P c 0.005) whsn the masrophngss were 
stimulated with cytokincs for 14 and 24 h. The data 
indicate that the increase of NO in macrophagcs may 
actually inhibit the oxidation of LDL under ox rxpcr- 
imcntnl conditions, In the prcscnsc of the NO synthasc 
inhibitor, the production of NO in stimulated cells was 
again reduced below the cndogcnous unstimulatcd level 
(Fig. 21, and TBARS formation was significantly clc- 
vatcd as compared CO stimulated cells without the inhib- 
itor (P c 0.005). The present study dcmonstratcd that 
the incrcasc of NO protects against macrophagc-mcdi- 
atcd LDL lipid pcroxidntion and that the inhibition of 
NO production rcvcrscd the phenomenon, The results 
do not support the hypothesis that NO reacts with su- 
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Fig. 3. Elcctrophorcdc mobility of LDL kckrc and after incubarion 
with macrophngcs. All LDL 5nmp!cs, caccpt for the lop lane, syfrc 
incuhtcd nt 37C for 24 h under thccenditians indicated. LDL wtxc 
incubntcd with nnd without stimulrrtsd macrophngm at37.C. Culture 
medium containing LDL (ariglnal concsntnrGon 0.1 mglml)~s con. 
ccntrutcd 5x prior to application on P 1% rgrrrcxx gel ;j yl) and 
foltowcd by FUR red 78 lipid stainin& Arrow indisata samgtc origin, 
peroxide to form cytotoxic peroxynitritc ions [26] which 
propagate LDL damage in the presence of masroph- 
agc5. 
Although TBARS have been frequently used to mcas- 
urc the cxtcnt of LDL lipid peroxidation. the assay is 
not highly specific for peroxide mcasuremcnt 
[ L2,l E&21,27,33,34]. Thcrcforc. WC also cxamincd chc 
change in clcctrophorctic mobility of LDL in an aga- 
rose gel, a technique widely used for dctcrmining the 
extent of LDL lipid pcroxidotion f12,35]. Fig, 3 shows 
that the mobility change of LDL modified by cytokinc- 
stimulated masrophngcs was less than that of LDL 
trcstcd with unstimulatcd macrophagcs. The addition 
of the NO inhibitor prcvcntcd the cffcsts of NO and 
rcstorcd the clcctromobilicy of LDL obscrvcd in the 
unstimularcd cultures. The dccrcascd mobility of LDL 
in stimulated macrophegcs i due CO the rcduc& oxida- 
tivc modification of apoB, the major protein moiety of 
LDL known to be modified by oxidized lipids [l4]. 
NO, a free radical, has a number of bioIogicaI astivi- 
tics and accordingiy has afind& mo& tiTls&tSi x- 
ccntly. It is a potent vasodilator clcascd from cndothc- 
lial cells and, under certain conditions, from macro- 
phagcs [23.24]. The role of NO in relation to athcro- 
137 
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&raris is not well understood. It is known that NOcsn 
react with and neutralize aupcroxidc ions, und may hy- 
po;hctic;rlly inhibit tipid pcroxidution [36]. In ;I cc&free 
in vitro expcrimcnt. Dee et nl. [37] htlvc shown that 
pcroxidution of LDL mtry bc cnhtrnced or suppressed 
by NO dcpcndiag on the rclutivc conccntracions of NO 
nnd hydrogen peroxide. It was thought that the rclcusr 
of NO from cndothcliul cells and mucrophugcs in coro- 
nary vcssch muy enhance the lipid pcroxiducion of LDL 
which huvc already been minimully oxidized inside the 
vcsscl [37-391, Thcrcforc, whether or nor the NO rudi- 
cols produscd by mucrophagcs enhance LDL lipid pcr- 
oxidation is u subject of controversy. Ths prcscnr study 
using cymokincs to stimulac NO production und an NO 
rynthusc inhibitor to suppress NO lcvcls suggests that 
NO may protccr ugainst macrophnyc-induced LDL ox- 
idation. The mcshnnism by which NO reduces LDL 
lipid pcroxidntion is not readily tlpparcnt from the prcs- 
cnt study. Gnc possibility is that NO rctlsts with the 
supcroxidc ion und inhibits its i;ctivity [36]. NO may 
also attenuate mctnl~catalyrcd lipid pcroxidation. IIS 
demonstrated in the system of myoglobin radials [38]. 
Furthermore, NO ecimulirtcs cellulnr gurmylatc yclusc 
to roisc the conccntrtition of cyclic gut\nosinc mono- 
phosp!latc(cGMP) [40] which may up-rtgL;latc the lcvcl 
of antioxidant cnqmcs. such US supcroxidc dismutusc 
(SOD) and ~alrrsc. More rcccntly, during rhc prcpuru- 
tion of this study. Rubrrnyi et ui, [41] und tieiw et al. 
[42] rcportccl that NO may cithcr inhibit or rcducc the 
production of 0; in other cell systems. These data sup- 
port our tinding that NO cxcrts a protective role in 
mucrophagc-mediated LDL pcroxidnrion, This protcc- 
tion role my in part account for thr pathogencsis of 
uthcrosclcrosis n animals deficient in NO (431. 
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